David Thomas Evans - 12 Jan 2026 Form 3 Insider Report for Cardlytics, Inc. (CDLX)

Role
Chief Financial Officer
Signature
/s/ Nick Lynton, Attorney-in-Fact
Issuer symbol
CDLX
Transactions as of
12 Jan 2026
Net transactions value
$0
Form type
3
Filing time
16 Jan 2026, 16:51:29 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Evans David Thomas Chief Financial Officer C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 4100, ATLANTA /s/ Nick Lynton, Attorney-in-Fact 16 Jan 2026 0001730451

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CDLX Common Stock 117,930 12 Jan 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney